The Pharma Letter12h
Phase IV Ingrezza data move focus from sales outlook
Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...
Valley Advocate4h
What is possible when you get to the root?: The peer-run Wildflower Alliance redefines mental health care, leaves the system in the dust
By Melissa Karen Sances For the Valley Advocate Her phone pinged and a grey bubble rose to the surface: “Are you ready to ...